seed
Stage
About
Vitranu develops TERC™, a tunable extended-release capsule technology designed to sustain delivery of therapeutics for eye diseases, aiming to reduce the frequency of injections required for treatment of wet Age-Related Macular Degeneration.
Explore Vitranu's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.